These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fluorination Effects on NOS Inhibitory Activity of Pyrazoles Related to Curcumin. Nieto CI; Cabildo MP; Cornago MP; Sanz D; Claramunt RM; Torralba MC; Torres MR; Elguero J; García JA; López A; Acuña-Castroviejo D Molecules; 2015 Aug; 20(9):15643-65. PubMed ID: 26343623 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine. Bryk R; Wolff DJ Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Handy RL; Moore PK Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895 [TBL] [Abstract][Full Text] [Related]
11. Effects of NO synthase inhibitors on the synovial microcirculation in the mouse knee joint. Veihelmann A; Krombach F; Refior HJ; Messmer K J Vasc Res; 1999; 36(5):379-84. PubMed ID: 10559678 [TBL] [Abstract][Full Text] [Related]
12. L-N6-(1-iminoethyl)-lysine (L-NIL) but not S-methylisothiourea sulphate (SMT) displays selectivity towards NOS-2. Chłopicki S; Olszanecki R; Jakubowski A; Lomnicka M; Gryglewski RJ Pol J Pharmacol; 1999; 51(5):443-7. PubMed ID: 10817546 [TBL] [Abstract][Full Text] [Related]
13. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors. Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739 [TBL] [Abstract][Full Text] [Related]
14. Fluorinated dihydroquinolines as potent n-NOS inhibitors. Jaroch S; Rehwinkel H; Hölscher P; Sülzle D; Burton G; Hillmann M; McDonald FM; Miklautz H Bioorg Med Chem Lett; 2004 Feb; 14(3):743-6. PubMed ID: 14741281 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Chatterjee PK; Patel NS; Kvale EO; Cuzzocrea S; Brown PA; Stewart KN; Mota-Filipe H; Thiemermann C Kidney Int; 2002 Mar; 61(3):862-71. PubMed ID: 11849439 [TBL] [Abstract][Full Text] [Related]
16. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Behr-Roussel D; Rupin A; Simonet S; Bonhomme E; Coumailleau S; Cordi A; Serkiz B; Fabiani JN; Verbeuren TJ Circulation; 2000 Aug; 102(9):1033-8. PubMed ID: 10961969 [TBL] [Abstract][Full Text] [Related]